Table 2.

Anticoagulant therapy.

Patients on anticoagulant drugs, n	aPLneg	aPLlow	aPLhigh	Total
None or discontinueda	990	173	73	1,236
Rivaroxaban	459	92	37	588
Apixaban	103	26	15	144
Edoxaban	14	4	1	19
Dabigatran	21	4	4	29
VKA	575	119	84	778
LMWH	225	57	34	316
Fondaparinux	32	2	3	37

LMWH, low molecular weight heparin; VKA, vitamin K antagonist.

^aAnticoagulant medication had been discontinued for at least 14 days.